Riskpilot← Back to searchSign inGet full accessOXYVISION HOLDING AS
ASActiveOrg 982023386Idrettsvegen 4, 6652 SurnadalEngineering activities and related technical consultancy · NACE 7112Est. 20005 employees
Revenue 2024
NOK 6,2M
+21% vs 2023
EBITDA margin
16.9%
+111% vs 2023
Equity ratio
88.8%
Financial strength
Net profit 2024
NOK 410K
+1263% vs 2023
| Revenue | NOK 6,2M | +21% |
| EBITDA | NOK 1,1M | +111% |
| Net profit | NOK 410K | +1263% |
| Total assets | NOK 25,6M | +3% |
| Equity | NOK 22,8M | -1% |
| Employees | 5 | — |
Legal name
OXYVISION HOLDING AS
Org number
982023386
Legal form
Aksjeselskap
NACE code
7112 · Engineering activities and related technical consultancy
Founded
24. mai 2000
Share capital
NOK 286 335
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Utvikling og salg av utstyr og tjenester til oppdrettsnæringen og hva hermed står i forbindelse, herunder å delta i andre selskaper.
Address
Idrettsvegen 4, 6652 Surnadal
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 15 862 | 10 765 | 3 716 | 5 154 | 6 227 |
| Staff expenses | −3 108 | −1 374 | −880 | −1 447 | −1 226 |
| EBITDA | 3 816 | −425 | −886 | 500 | 1 055 |
| Depreciation & amort. | −1 037 | −501 | −364 | −581 | −680 |
| EBIT | 2 779 | −926 | −1 250 | −81 | 375 |
| Net financials | −13 | −35 | 47 584 | 33 | −1 |
| Profit before tax | 2 766 | −961 | 46 334 | −48 | 374 |
| Tax | 198 | −243 | −56 | −13 | −36 |
| Net profit | 2 568 | −718 | 46 390 | −35 | 410 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 19 929 | 19 102 | 27 091 | 24 781 | 25 644 |
| Equity | 17 173 | 16 455 | 24 084 | 23 049 | 22 759 |
| Long-term debt | 0 | 0 | 0 | 0 | 1 000 |
| Short-term debt | 2 757 | 2 647 | 3 007 | 1 732 | 1 885 |
| Total debt | 2 757 | 2 647 | 3 007 | 1 732 | 2 885 |
EBITDA margin
16.9%
This company
15.8%
Market median
+7% vs market
20202024
Equity ratio
88.8%
This company
38.2%
Market median
+132% vs market
20202024
Return on equity
1.8%
This company
18.4%
Market median
-90% vs market
20202024
Net profit margin
6.6%
This company
8.1%
Market median
-19% vs market
20202024
Asset turnover
0.24×
This company
1.12×
Market median
-79% vs market
20202024
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MG Chief Executive Officer | Chief Executive Officer | 2000 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2010 | |
| Chairman | 2010 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.55% | 33.55% | 2024 | |
| Company | 28.18% | 28.18% | 2024 | |
| Company | 18.62% | 18.62% | 2024 | |
| Company | 7.92% | 7.92% | 2024 | |
| Individual | 4.76% | 4.76% | 2024 | |
| Company | 4.68% | 4.68% | 2024 | |
| Company | 2.29% | 2.29% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ant As
OXYVISION HOLDING AS Board members of OXYVISION HOLDING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Martin Gausen | Chief Executive Officer | 0 companies |
| Nils Kåre Hovden | Board of Directors | 0 companies |
| Jon Gausen | Chairman | 0 companies |